Paris medtech developing biowearable technology to ease the burden of chronic kidney disease patients.
| Date | Round | Amount |
|---|---|---|
| Mar 2024 | Pre Seed Metyos raised EUR2.3M in pre-seed funding led by Cenitz to develop its CKD biowearable and progress through clinical trials toward FDA clearance. | $2.5M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.